Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (ETANERCEPT) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study

✍ Scribed by Yanik, Gregory; Ho, Vincent T.; Horowitz, Mary; Weisdorf, Daniel J.; Logan, Brent R.; Wu, Juan; Soiffer, Robert J.; Wingard, John R.; Levine, John E.; Ferrara, James L.M.; Giralt, Sergio A.; White, Eric; Carter, Shelly L.; DiFronzo, Nancy; Cooke, Kenneth R.

• Book ID: 122428633
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 53 KB
• Volume: 19
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2012.11.141